Skip to content

Patient Satisfaction After Patient-specific Jawline Augmentation

Patient Satisfaction After Patient-specific Jawline Augmentation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03932734
Enrollment
26
Registered
2019-05-01
Start date
2019-06-30
Completion date
2020-01-31
Last updated
2019-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Deformity of Face, Post-traumatic Deformity

Keywords

Satisfaction, Jawline augmentation, Transgender, Cosmetic jaw angle

Brief summary

The survey studies patient satisfaction after titanium patient specific jawline augmentation in congenital, post-trauma, deformity and transgender/cosmetic jaw angle/border deficiencies.

Detailed description

Additively manufactured titanium implants have been pre-designed in the hospital department, further designed and manufactured by 2 Belgian companies. The issue is if all patients have satisfactory perception of the improvement of their morphology and the actual outcome of the procedure, and how theur social ineractions are perceived today.

Interventions

OTHERsurvey

Face-Q conversion table

Sponsors

Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

\- All lower jaw augmentation implants

Exclusion criteria

\- N/A

Design outcomes

Primary

MeasureTime frameDescription
Satisfaction/Quality of Life1 yearBy means of 4 surveys (social, psychological, outcome and satisfaction) based on FACE-Q. The scales can be used independently of the other scales.Higher scores reflect a better outcome. If missing data is less than 50% of the scale's items, insert the mean of the completed items. Use the Conversion Table to convert the raw summed scale score into a score from 0 (worst) to 100 (best).

Countries

Belgium

Contacts

Primary ContactVeerle Van Mossevelde, SC
veerle.vanmossevelde@uzbrussel.be+3224763134

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026